<DOC>
	<DOCNO>NCT01302951</DOCNO>
	<brief_summary>The aim study provide data pharmacokinetics ( PK ) moxifloxacin ( MXF ) serum liver tissue patient undergo liver resection due primary secondary tumor liver .</brief_summary>
	<brief_title>Penetration Moxifloxacin Into Liver Tissue Patients Undergoing Liver Resection .</brief_title>
	<detailed_description>After give informed consent , patient schedule plan liver resection enrol study . The patient receive MXF 400 mg one hour intravenous infusion randomize timed interval prior liver resection . Blood healthy liver tissue sample 34 patient administration MXF . Plasma sample concomitantly . In subgroup 19 patient , additional serum specimen obtain 2 , 4 , 8 , 12 , 24 , 36 48 h establish PK . The pharmacokinetic parameter MXF calculate apply two-compartment model .</detailed_description>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>age 1880 year old elective liver resection liver tumor female : pregnancy test negative Subjects willing able give fully inform write consent subject contraindication Moxifloxacin subject therapy Moxifloxacin within 2 week recruitment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>liver resection</keyword>
</DOC>